<DOC>
	<DOCNO>NCT01412372</DOCNO>
	<brief_summary>The purpose study evaluate effect long act mesalamine ( Lialda ) patient Post-Infective Irritable Bowel Syndrome ( PI-IBS ) . The investigator evaluate gastrointestinal symptom , IBS specific quality life ( IBS-QOL ) , plasma cytokine treatment Lialda .</brief_summary>
	<brief_title>The Effect Long-Acting Mesalamine Post-Infective Irritable Bowel Syndrome- A Pilot Study</brief_title>
	<detailed_description>This study test long act mesalamine management PI-IBS . It potential improve QOL perhaps gastrointestinal symptom , patient PI-IBS . The result study , positive , provide preliminary data large scale clinical trial . This study also provide information plasma cytokines patient PI-IBS whether improvement symptom correlate improvement plasma cytokine .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Inclusion Criteria 1 . Men woman age 1875 year 2 . Rome III criterion IBS 3 . Symptom onset apparent acute gastroenteritis 4 . Symptoms 6 month great duration 5 . Normal gross appearance colonic mucosa erythema 6 . Negative marker celiac disease inflammatory bowel disease 7 . Normal thyroid function serum calcium 8 . Stable medication regimens medical condition . 1 . Age &lt; 18 &gt; 75 year 2 . Previous diagnosis history compatible IBS 3 . Constipationpredominant IBS . 4 . Clinically significant chronic cardiac , pulmonary , hepatic , renal dysfunction HIV 5 . History of/or presence malignancy 6 . Current evidence gastrointestinal disorder celiac disease , inflammatory bowel disease , chronic pancreatitis , scleroderma , HIV , small bowel colonic resection , paraplegia quadriplegia . . 7 . Current evidence drug alcohol abuse judge investigator 8 . Allergy mesalamine aspirin 9 . Investigator perception patient 's inability comply study protocol 10 . Unstable psychiatric disease 11 . Recent change gastrointestinal medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Mesalamine</keyword>
	<keyword>Gastroenteritis</keyword>
	<keyword>abdominal pain</keyword>
	<keyword>hypersensitivity</keyword>
</DOC>